| May'19 | May'18 | May'17 | May'16 | May'15 | May'14 | May'13 | May'12 | May'11 | May'10 |
|---|---|---|---|---|---|---|---|---|---|
Net sales | |||||||||
270,634 | 261,655 | 269,788 | 353,890 | 356,534 | 354,425 | 341,916 | 221,917 | 215,750 | 216,035 |
Cost of sales (exclusive of intangible amortization) | |||||||||
114,634 | 117,799 | 125,838 | 179,574 | 180,738 | 174,251 | 173,402 | 96,608 | 90,047 | 89,066 |
Gross profit | |||||||||
156,000 | 143,856 | 143,950 | 174,316 | 175,796 | 180,174 | 168,514 | 125,309 | 125,703 | 126,969 |
Operating expenses: | |||||||||
Research and development | |||||||||
28,258 | 24,338 | 24,148 | 25,053 | 26,594 | 28,124 | 26,319 | 20,511 | 21,373 | 19,275 |
Sales and marketing | |||||||||
76,829 | 73,109 | 74,865 | 83,743 | 82,351 | 85,305 | 76,121 | 64,505 | 58,123 | 60,923 |
General and administrative | |||||||||
34,902 | 30,991 | 31,133 | 30,583 | 30,031 | 26,902 | 26,186 | 19,033 | 17,828 | 16,437 |
Amortization of intangibles | |||||||||
17,100 | 13,900 | 14,600 | 17,964 | 17,966 | 16,600 | 16,617 | 9,309 | 9,234 | 9,463 |
Change in fair value of contingent consideration | |||||||||
-6,776 | 250 | -15,261 | 948 | -8,096 | -1,908 | 1,583 | 0 | 0 | - |
Acquisition, restructuring and other items, net | |||||||||
15,127 | 15,432 | 27,510 | 12,591 | 26,257 | 10,873 | 13,800 | 15,859 | 7,182 | - |
Medical device excise tax | |||||||||
0 | 0 | -1,837 | 2,416 | 4,142 | 3,829 | 1,600 | 0 | 0 | - |
Total operating expenses | |||||||||
165,396 | 158,026 | 155,125 | 173,298 | 179,245 | 169,687 | 162,226 | 129,217 | 113,740 | 106,098 |
Operating loss | |||||||||
-9,396 | -14,170 | -11,175 | 1,018 | -3,449 | 10,487 | 6,288 | -3,908 | 11,963 | 20,871 |
Other (expenses) income: | |||||||||
Interest expense, net | |||||||||
5,099 | 3,062 | 2,839 | 3,385 | 3,193 | 3,656 | 5,271 | 508 | 499 | 672 |
Interest income | |||||||||
- | - | - | - | - | 0 | 103 | 1,090 | 737 | 713 |
Other expense | |||||||||
207 | 31 | 281 | 886 | 1,489 | 1,645 | 2,707 | 2,096 | 1,503 | 1,293 |
Other expense, net | |||||||||
-5,306 | -3,093 | -3,120 | -4,271 | -4,682 | -5,301 | -7,875 | -1,514 | -1,265 | -1,252 |
Loss from continuing operations before income tax benefit | |||||||||
-14,702 | -17,263 | -14,295 | -3,253 | -8,131 | 5,186 | -1,587 | -5,422 | 10,698 | 19,619 |
Income tax benefit | |||||||||
-3,556 | -11,036 | -7,243 | 40,337 | -4,743 | 2,839 | -376 | -239 | 2,581 | 7,307 |
Net loss from continuing operations | |||||||||
-11,146 | -6,227 | -7,052 | - | - | - | - | - | - | - |
Income from discontinued operations, net of income tax | |||||||||
72,486 | 22,562 | 12,060 | - | - | - | - | - | - | - |
Net income (loss) | |||||||||
61,340 | 16,335 | 5,008 | -43,590 | -3,388 | 2,347 | -1,211 | -5,183 | 8,117 | 12,312 |
Loss per share continuing operations - basic (usd per share) | |||||||||
-0.30 | -0.17 | -0.19 | - | - | - | - | - | - | - |
Loss per share continuing operations - diluted (usd per share) | |||||||||
-0.30 | -0.17 | -0.19 | - | - | - | - | - | - | - |
Income per share discontinued operations - basic (usd per share) | |||||||||
1.93 | 0.61 | 0.33 | - | - | - | - | - | - | - |
Income per share discontinued operations - diluted (usd per share) | |||||||||
1.93 | 0.61 | 0.33 | - | - | - | - | - | - | - |
Income (loss) per share | |||||||||
Basic (in usd per share) | |||||||||
1.64 | 0.44 | 0.14 | -1.21 | -0.09 | 0.07 | -0.03 | -0.20 | 0.33 | 0.50 |
Diluted (in usd per share) | |||||||||
1.64 | 0.44 | 0.14 | -1.21 | -0.09 | 0.07 | -0.03 | -0.20 | 0.32 | 0.50 |
Basic weighted average shares outstanding (in shares) | |||||||||
37,484 | 37,075 | 36,616 | 36,161 | 35,683 | 35,135 | 34,817 | 25,382 | 24,870 | 24,580 |
Diluted weighted average shares outstanding (in shares) | |||||||||
37,485 | 37,074 | 36,616 | 36,161 | 35,683 | 35,439 | 34,817 | 25,382 | 25,132 | 24,787 |